Cura Therapeutics Inc.

Cura Therapeutics Inc. is a biotech startup founded in 2020 with a vision to develop first-in-class immunotherapies targeting cancer and infectious diseases. The company's slogan "Developing First-in-class Immunotherapies to Treat Cancer & Infectious Diseases" captures its commitment to pioneering treatment solutions. Cura's innovative approach involves harnessing cytokines and immune receptors to create multifunctional proteins with potent anti-cancer and anti-viral properties. The company operates within the Biotechnology, Health Care, Health and Wellness sectors, demonstrating a broad scope of applications for its technology. As of now, no specific details about the company's headquarter or last investment have been disclosed, indicating a potential opportunity for investment and collaboration in this promising venture.